GlassScriptPhysician profile
Jessica A Tyrell
NPI 1699075333
$6,016.73
in general payments reported to CMS, 2019-2025
13 companies · $2,997 in 2025
The $2,997 reported for 2025 was more than what 97% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $243 · 2022: $495 · 2023: $1,120 · 2024: $1,162 · 2025: $2,997.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,166 · Travel and Lodging: $920 · Consulting Fee: $150 · Education: $42.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,166.27 |
| Travel and Lodging | $919.92 |
| Consulting Fee | $150.00 |
| Education | $42.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $3,358.11 | 2021-2025 | Inspire |
| Jazz Pharmaceuticals INC. | $1,336.67 | 2022-2025 | |
| Axsome Therapeutics, INC. | $340.17 | 2023-2025 | Sunosi |
| Harmony Biosciences LLC | $301.21 | 2021-2025 | Wakix |
| Zoll Respicardia, INC. | $214.74 | 2023-2024 | Remede System |
| Avadel Cns Pharmaceuticals, LLC | $191.48 | 2024-2025 | Lumryz |
| Idorsia Pharmaceuticals US INC | $91.97 | 2023-2025 | Quviviq, Quviviq |
| Philips North America LLC | $74.89 | 2021 | |
| Electromed, INC. | $26.45 | 2024 | Smartvest |
| Eisai INC. | $26.31 | 2025 | |
| Breas Medical, INC. | $22.97 | 2025 | Vivo 45 Ls, Vivo 1/2 |
| Resmed Corp | $16.68 | 2022 | |
| Exact Sciences Corporation | $15.08 | 2023 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jessica Tyrell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.